Health Condition 1: O269- Pregnancy related conditions, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: � Mother must be a participant in the A-PLUS trial � Infant must be enrolled prior to discharge from the hospital after delivery � Family must be planning to remain in the Nagpur area for the next 12 months
Exclusion criteria
Exclusion criteria: � Infants with multiple congenital anomalies (e.g., cyanotic congenital heart disease, spina bifida, or other nervous system malformations) will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Infant length (length-for-age z-score)Timepoint: at 24-hrs, 1-week, 6-weeks and 3, 6, 9 and 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Outcome TimePoints ââ?¬Â¢ Additional growth indicators (weight-for-age and weight-for-length z-scores, middle-upper-arm-circumference and head circumference)Timepoint: at 5 time points (24-hours, 1-week, 6-weeks and 3, 6, & 9 months;ââ?¬Â¢ Antibiotic levels in womenââ?¬â?¢s breastmilkTimepoint: at 5 time points (24-hours, 1-week, 6-weeks and 3, 6, & 9 months;ââ?¬Â¢ Infant GI microbiome indicators (alpha diversity, beta diversity, relative abundance of different taxa, metabolic capacity)Timepoint: at 5 time points (24-hours, 1-week, 6-weeks and 3, 6, & 9 months;ââ?¬Â¢ Maternal breastmilk and aereolar skin microbiome indicators (alpha diversity, beta diversity, relative abundance of different taxa)Timepoint: at 5 time points (24-hours, 1-week, 6-weeks and 3, 6, & 9 months | — |
Countries
India
Contacts
Lata Medical Research Foundation